Better Therapeutics (NASDAQ:BTTX) stock is rising higher on Monday despite a lack of news from the biotechnology company.
While there’s no news from the company today, we are seeing heavy trading of its shares. As of this writing, more than 25 million shares of the stock have been traded. That’s quite the jump compared to the company’s daily average trading volume of about 182,000 shares.
So without any news from the company, what’s behind this massive increase in trading volume? It looks like investors can thank retail traders for boosting shares of BTTX stock higher today. There’s plenty of chatter concerning the stock on social media.
While BTTX shares are on the rise right now, investors may not want to start chasing it right now. There’s no guarantee the stock will continue rising and all it’ll take is one quick dump to drop the prices of the shares again.
This is something we’ve seen happen plenty of times in the past as investors pump up shares of penny stocks only to dump them later for a profit. This can leave unsuspecting traders holding the bag if they aren’t careful.
BTTX stock is up 28.3% as of Monday morning but is down 75.5% since the start of the year.
Investors on the lookout for more stock market news are in the right place!
InvestorPlace has all the latest stock news that traders need to know about on Monday! A few examples include other short squeeze stocks to watch, what’s going on with Chinese stocks, as well as the most recent SoundHound AI (NASDAQ:SOUN) stock news. You can learn all about these topics at the following links!
More Monday Stock Market News
- Short Squeeze Stocks: HCDI, ZYME and 3 Others Experts Think Are Ready to Pop
- Chinese EV Stocks News: Why Are NIO, XPEV, LI Stocks in the Spotlight Today?
- Why Is SoundHound AI (SOUN) Stock Up 30% Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed